Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Moreira

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Dermatology and Therapy|July 14, 2025
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)Jonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.
Pediatric Pulmonology|May 13, 2026
Urine Metabolomics to Predict Bronchopulmonary Dysplasia: A Single-Center Prospective StudyLauren Strauch, Patrick Lang, Zoya Cheema, et al.
The British Journal of Dermatology|June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Respiratory Research|May 24, 2024
Rates of bronchopulmonary dysplasia in very low birth weight neonates: a systematic review and meta-analysisAlvaro Moreira, Michelle Noronha, Jooby Joy, et al.
Eclinicalmedicine|September 14, 2020
Multisystem inflammatory syndrome in children: A systematic reviewMubbasheer Ahmed, Shailesh Advani, Axel Moreira, et al.
Dermatology and Therapy|June 26, 2025
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic DermatitisJonathan I Silverberg, Melinda Gooderham, Andreas Wollenberg, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 6, 2022
Development of a peripheral blood transcriptomic gene signature to predict bronchopulmonary dysplasiaAlvaro Moreira, Miriam Tovar, Alisha M Smith, et al.
Frontiers in Physiology|July 7, 2023
The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomesMohamed Ahmed, Nancy G Casanova, Nahla Zaghloul, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2018
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitorsAlvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.
Pediatric Research|July 10, 2025
Bronchopulmonary dysplasia in preterm neonates: Th2-Eosinophilic inflammation and asthma-like featuresAlvaro Moreira, Manissa Coleman, Khyzer Aziz, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Dermatology and Therapy|July 14, 2025
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)Jonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.
Pediatric Pulmonology|May 13, 2026
Urine Metabolomics to Predict Bronchopulmonary Dysplasia: A Single-Center Prospective StudyLauren Strauch, Patrick Lang, Zoya Cheema, et al.
The British Journal of Dermatology|June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Respiratory Research|May 24, 2024
Rates of bronchopulmonary dysplasia in very low birth weight neonates: a systematic review and meta-analysisAlvaro Moreira, Michelle Noronha, Jooby Joy, et al.
Eclinicalmedicine|September 14, 2020
Multisystem inflammatory syndrome in children: A systematic reviewMubbasheer Ahmed, Shailesh Advani, Axel Moreira, et al.
Dermatology and Therapy|June 26, 2025
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic DermatitisJonathan I Silverberg, Melinda Gooderham, Andreas Wollenberg, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 6, 2022
Development of a peripheral blood transcriptomic gene signature to predict bronchopulmonary dysplasiaAlvaro Moreira, Miriam Tovar, Alisha M Smith, et al.
Frontiers in Physiology|July 7, 2023
The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomesMohamed Ahmed, Nancy G Casanova, Nahla Zaghloul, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2018
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitorsAlvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.
Pediatric Research|July 10, 2025
Bronchopulmonary dysplasia in preterm neonates: Th2-Eosinophilic inflammation and asthma-like featuresAlvaro Moreira, Manissa Coleman, Khyzer Aziz, et al.
Pageof 12